Every SEC Form 3/4/5 on record for this filer (CIK 1553053) — 6 issuers, 41 transactions. Section-16 filings only: what they filed, not a biography, and titles are as filed on their latest form at each issuer.
| Ticker | Company | Role as filed | On file | Forms | Open-market net |
|---|---|---|---|---|---|
| BFAM | BRIGHT HORIZONS FAMILY SOLUTIONS INC. | Director | 2016-05-13 → 2026-06-05 | 16 | −$878,898 |
| MRSN | Mersana Therapeutics, Inc. | Director | 2017-09-07 → 2026-01-06 | 26 | $39,785 |
| GRTX | Galera Therapeutics, Inc. | Director | 2019-11-06 → 2025-02-26 | 12 | $97,628 |
| ADAP | Adaptimmune Therapeutics PLC | Director | 2016-01-04 → 2024-07-01 | 13 | $74,050 |
| TSRO | TESARO, Inc. | Director · lapsed | 2016-06-03 → 2019-01-22 | 5 | −$307,920 |
| MIRN | Mirna Therapeutics, Inc. | Director · lapsed | 2015-09-30 → 2016-09-06 | 4 | — |
| Ticker | Date | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| BFAM | 2023-12-01 | Sell | 680 | $88.59 | $60,241 | 9,362 |
2 of 6 issuers are covered and open a security page; the rest are on file here only.
